| Arboviruses | Molecules | Properties | Viruses | Cell types | Approaches used to identify/verify the receptors | Interacted viral components | References |
|---|---|---|---|---|---|---|---|
| Mosquito-Borne Flaviviruses | DC-SIGN/L-SIGN/LSECtin | C-type lectins | DENV, WNV, JEV, ZIKV | Mammalian | Binding assays; Immunofluorescence; RNAi assays; Antibody blocking assay; Infection assays in overexpressed non-permissive cell lines; Cryo-EM | prM/E proteins | (Davis et al., 2006; Dejnirattisai et al., 2011; Liu, Ridilla, et al., 2017; Pokidysheva et al., 2006; Wang et al., 2016) |
| Mannose receptor | DENV | Mammalian | Binding Assays; Blot overlay; Immunofluorescence | E protein | McFadden et al. (2008) | ||
| CLEC5A | DENV, JEV, ZIKV | Mammalian, Insect | Infection assays in overexpressed non-permissive cell lines; Immunofluorescence; Antibody blocking assay in cell lines and animal models; Flow cytometry | E protein | (Chen et al., 2008, Chen et al., 2012) | ||
| mosGCTL-1/3/7 | WNV, DENV, JEV | Insect | Genome-wide RNAi screening; RNAi assays; immunofluorescence; CO-IP | E protein | (Cheng et al., 2010; Liu et al., 2014, 2017a) | ||
| TIM receptors | Phosphatidylserine receptors | DENV, WNV, JEV, ZIKV, YFV | Mammalian | Gain-of-function cDNA screening; Infection assays in overexpressed non-permissive cell; Flow Cytometry; Antibody blocking assay; Immunofluorescence | E protein | (Hamel et al., 2015; Meertens et al., 2012; Niu et al., 2018) | |
| TAM receptors | DENV, ZIKV | Mammalian | Gain-of-function cDNA screen; RNAi assays; Infection assays in overexpression/knockout cell lines; Flow Cytometry; Antibody blocking assay; Immunofluorescence | E protein | (Meertens et al., 2012, 2017; Richard et al., 2017) | ||
| CD300a | DENV, YFV | Mammalian | cDNA library screening; Infection assays in overexpressed cell lines; Flow Cytometry; RNAi assays; Antibody blocking assay | E protein | Carnec et al. (2016) | ||
| Integrin αvβ3 | Integrin family | WNV, JEV | Mammalian | VOPBA; Antibody blocking assay; RNAi assays; Immunofluorescence; Flow Cytometry | E protein | (Chu and Ng, 2004; Chu & Ng, 2004; Fan et al., 2017; Schmidt et al., 2013) | |
| Integrin αvβ5 | ZIKV | Mammalian | CRISPR-Cas9 screening; Infection assays in knockout/overexpression cell lines assays; Immunofluorescence; Antibody blocking assay | Viral particle | Wang et al. (2020) | ||
| HS/HSPG | Glycosaminoglycans | DENV, JEV, ZIKV, YFV | Mammalian | Binding assays; GAG-deficient cell infection assays; In vivo bioluminescence imaging; RNAi assays | E protein | (Gao et al., 2019; Germi et al., 2002; Okamoto et al., 2012; Su et al., 2001) | |
| 37kDa/67 kDa Laminin receptor | High-affinity laminin receptor | DENV, JEV | Mammalian, Insect | VOPBA; Binding assays; Liquid chromatography-mass spectrometry (MS); Antibody blocking assay | E protein | (Thepparit & Smith, 2004; Thongtan et al., 2012) | |
| GRP78/HSP70/90 | Heat shock protein family | DENV, ZIKV, JEV | Mammalian, Insect | VOPBA; Cell heat shock assay; Antibody blocking assay; RNAi assays; Immunofluorescence; Immunolocalization | E protein | (Das et al., 2009; Hung et al., 2011; Pujhari et al., 2019; Reyes-del Valle et al., 2005) | |
| NKp44 | Natural cytotoxicity receptor family | DENV, WNV | Mammalian | Elisa; Antibody blocking assay; Flow cytometry; Cytotoxicity assays | E protein | Hershkovitz et al. (2009) | |
| Prohibitin-1 | Prohibitin family | DENV | Mammalian, Insect | VOPBA; RNAi assays; Antibody blocking assay; Immunofluorescence | E protein | (Kuadkitkan et al., 2010; Sharma et al., 2020) | |
| Claudin-1 | Claudin family | DENV | Mammalian | Yeast two-hybrid (Y2H) screening; Pull-down assays; RNAi assays | prM/M protein | Che et al. (2013) | |
| nLc4Cer/GM1a/GM3 | Glycosphingolipid | DENV | Mammalian, Insect | TLC/virus-binding and TLC immunostaining assays; Confocal microscope imaging; MS analysis; ITC; RNAi assays | E protein | (Tantirimudalige et al., 2022; Wang et al., 2016; Wichit et al., 2011) | |
| NCAM1 | NCAM family | ZIKV | Mammalian | Proximity labeling using chemical labeled ZIKV particles; LC–MS/MS analysis; Immunoprecipitation; CRISPR-Cas9 knockout assays; Immunofluorescence | Viral particle | Srivastava et al. (2020) | |
| LDLR | LDLR family | JEV | Mammalian | RNAi assays; CO-IP; Immunofluorescence; Antibody blocking assay; animal assays | E protein | Huang et al. (2021) | |
| Defensin/LRP2 | Antimicrobial peptides | JEV | Insect | RNAi assays; Immunofluorescence; Antibody blocking assay | E protein | Liu et al. (2020) | |
| Vimentin | Intermediate filament protein | JEV | Mammalian | Entry blocking assays; Pull-down | E protein | (Zhang et al., 2024, Zhang et al., 2024) | |
| CD4/CD14 | Transmembrane glycoprotein | JEV | Mammalian | VOPBA; Binding assays; LC-MS; Antibody blocking assay | E protein | (Thongtan et al., 2012; Wang et al., 2023) | |
| PLVAP/GKN3 | Transmembrane glycoprotein/Gastrokine family | JEV | Mammalian | Pull down with 2-DE separation and MS; Infection assays in overexpression cell lines; RNAi assays; Antibody blocking assay; Immunofluorescence | E protein | Mukherjee et al. (2018) | |
| Mosquito-Borne Alphaviruses | LDLRAD3 | LDLR family | VEEV | Mammalian | CRISPR–Cas9 screening; Infection assays in knockout/overexpressed cell lines and animal models; Surface plasmon resonance; In vivo imaging; Cryo-EM; Site-directed mutagenesis | E2–E1 heterodimers | (Basore et al., 2021; Ma et al., 2020, 2021) |
| VLDLR | SFV, EEEV, SINV | Mammalian, Insect | CRISPR-Cas9 screening; Infection assays in overexpressed cell lines; Entry blocking assays; Biolayer interferometry binding assays; Confocal microscopy; Cryo-EM | SFV E1 protein, EEEV E2 protein |
(Adams et al., 2024; Cao et al., 2023; Clark et al., 2021) | ||
| ApoER2 | SFV, EEEV, SINV | Mammalian | CRISPR-Cas9 screening; Infection assays in knockout/overexpressed cell lines; Entry blocking assays; Binding assays; Confocal microscopy | Viral particle | Clark et al. (2021) | ||
| LDLR | EEEV, WEEV, SFV, RRV, GETV, BEBV | Mammalian | Host membrane protein expression library screen; Infection assays in knockout/overexpression cell lines assays; Co-IP; Binding assays; Entry blocking assays | E1 and E2 proteins | (Ma et al., 2024; Zhai et al., 2024) | ||
| MXRA8 | Transmembrane glycoprotein | CHIKV, RRV, ONNV, MAYV, SINV, WEEV, GETV | Mammalian, Avian | CRISPR-Cas9 screening; Co-IP; Mass Spectrometry; Binding assays; Infection assays in knockout/overexpression cell lines and animal models; X-ray Crystallography; Cryo-EM | E1 and E2 proteins | (Basore et al., 2019; Kim et al., 2020; Song et al., 2019; Zhang et al., 2018; Zimmerman et al., 2023) | |
| NRAMP/NRAMP2 | NRAMP family | SINV | Mammalian, Insect | RNAi assays; Immunofluorescence | Viral particle | Rose et al. (2011) | |
| CD147 | Transmembrane glycoprotein | EEEV, WEEV, SINV, CHIKV, RRV | Mammalian | CRISPR-Cas9 screening; CRISPR-Cas9 knockout and complement assays | E2 protein | De Caluwé et al. (2021) | |
| Prohibitin-1 | Prohibitin family | CHIKV | Mammalian | 2D-VOPBA; Antibody blocking assay; CO-IP; Immunofluorescence; RNAi assays | E2 protein | Wintachai et al. (2012) | |
| 37kDa/67 kDa Laminin receptor | High-affinity laminin receptor | SINV, VEEV | Mammalian | Antibody blocking assay; Immunoprecipitation; Flow cytometry | E2 protein | (Malygin et al., 2009; Wang et al., 1992) | |
| TIM receptors | Phosphatidylserine receptors | CHIKV, RRV, SINV, EEEV | Mammalian | Infection assays in overexpressed non-permissive cell lines; Antibody blocking assay; Single particle tracking; Confocal microscope imaging | E2 protein | (Kirui et al., 2021; Moller-Tank & Maury, 2014; Pierson et al., 2020) | |
| TAM receptors | Phosphatidylserine receptors C-type lectins |
RRV, SINV | Mammalian | Infection assays in overexpressed non-permissive cell lines; Entry blocking assays; Flow cytometry | Viral particle | (Pierson et al., 2020) | |
| CD300a | SINV | Mammalian | cDNA library screening; Infection assays in overexpressed non-permissive cell lines | Viral particle | Carnec et al. (2016) | ||
| DC-SIGN/L-SIGN | SINV | Mammalian, Insect | Flow cytometry; Immunofluorescence; Infection assays in overexpressed non-permissive cell lines | E1 and E2 proteins | Klimstra et al. (2003) | ||
| HS/HSPG | Glycosaminoglycans | SINV, CHIKV, SFV, RRV, EEEV, VEEV | Mammalian | Binding assays; Infection assays in HS/GAG-deficient cell lines; In vivo imaging | E2 protein | (Gardner et al., 2011; McAllister et al., 2020; Ryman et al., 2007; Smit et al., 2002) | |
| Integrin α1β1 | Integrin family | RRV | Mammalian | Antibody blocking assay; Elisa | E2 protein | La Linn et al. (2005) | |
| ATP synthase β subunit | ATPase alpha/beta chains family | CHIKV | Insect | VOPBA; Mass Spectrometry; Antibody blocking assay; RNAi assays; Confocal microscope imaging | E2 protein | Fongsaran et al. (2014) | |
| Mosquito-Borne Bunyaviruses | LRP1 | LDLR family | RVFV, OROV | Mammalian | CRISPR-Cas9 screening; Infection assays in overexpression/knockout cell line assays; Antibody blocking assay; Biolayer interferometry binding assays; Immunofluorescence | Gn glycoproteins | (Ganaie et al., 2021; Schwarz et al., 2022) |
| DC-SIGN/L-SIGN | C-type lectins | RVFV, LACV, OROV | Mammalian | Binding assays; Immunofluorescence; Infection assays in overexpressed non-permissive cell lines; Flow cytometry | Gn/Gc glycoproteins | (Léger et al., 2016; Lozach et al., 2011) | |
| HS/HSPG | Glycosaminoglycans | RVFV | Mammalian | Infection assays in HS/GAG-deficient cell lines; Immunofluorescence; Binding assays | Viral particle | (de Boer et al., 2012; Riblett et al., 2016) |